1. Ovarian Cancer Survival: Steady Improvement, Despite Rhetoric to the Contrary

   • Maurie Markman

   Invited Commentary 10 August 2013 Pages: 433 - 435

2. Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia: To Whom, When, and How

   • John Magenau
   • Daniel R. Couriel

   Leukemia (A Aguayo, Section Editor) 21 August 2013 Pages: 436 - 444

3. Acute Promyelocytic Leukemia: Do We Have a New Front-Line Standard of Treatment?

   • Miguel A. Sanz
   • Gloria Iacoboni
   • Pau Montesinos

   Leukemia (A Aguayo, Section Editor) 29 August 2013 Pages: 445 - 449

4. Genetic Factors and Pathogenesis of Waldenström’s Macroglobulinemia

   • Jorge Monge
   • Esteban Braggio
   • Stephen M. Ansell

   Lymphomas (PA Hamlin, Section Editor) 31 July 2013 Pages: 450 - 456

   

5. Therapeutic Options for Adult T-Cell Leukemia/Lymphoma

   • Ambroise Marçais
   • Felipe Suarez
   • Ali Bazarbachi

   Lymphomas (PA Hamlin, Section Editor) 14 August 2013 Pages: 457 - 464

   

6. Current Treatment of Locoregional Recurrence of Melanoma

   • Malcolm Hart Squires III
   • Keith A. Delman

   Melanoma (KB Kim, Section Editor) 02 August 2013 Pages: 465 - 472

7. MEK Inhibition in the Treatment of Advanced Melanoma

   • April K. S. Salama
   • Kevin B. Kim

   Melanoma (KB Kim, Section Editor) 23 August 2013 Pages: 473 - 482

   

8. Melanoma Brain Metastases: an Unmet Challenge in the Era of Active Therapy

   • Vikram Gorantla
   • John M. Kirkwood
   • Hussein A. Tawbi

   Melanoma (KB Kim, Section Editor) 17 August 2013 Pages: 483 - 491

9. Inhibition of Angiogenesis for the Treatment of Metastatic Melanoma

   • Aaron S. Mansfield
   • Svetomir N. Markovic

   Melanoma (KB Kim, Section Editor) 05 September 2013 Pages: 492 - 499

10. Checkpoint Modulation in Melanoma: An Update on Ipilimumab and Future Directions

    • David B. Page
    • Michael A. Postow
    • Jedd D. Wolchok

    Melanoma (KB Kim, Section Editor) 10 August 2013 Pages: 500 - 508